| Cityview Healthcare And Rehabilitation | |
| 6606 Carnegie Ave, Cleveland, Ohio 44103 | |
| (216) 361-1414 | |
| Name | Cityview Healthcare And Rehabilitation |
|---|---|
| Location | 6606 Carnegie Ave, Cleveland, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 150 |
| Occupancy Rate | 74.73% |
| Medicare ID (CCN) | 365879 |
| Legal Business Name | Aj Cityview Nursing & Rehab Opco Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1457855983 |
| Organization Name | AJ CITYVIEW NURSING & REHAB OPCO LLC |
| Address | 6606 Carnegie Ave, Cleveland, OH 44103 |
| Phone Number | 216-361-1414 |
News Archive
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.
BioMimetic Therapeutics, Inc. announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).
Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.
The Life Sciences Discovery Fund (LSDF) today announced $1.1 million in five Proof of Concept grants to Washington for-profit and non-profit organizations to foster the translation of health-related products from the laboratory into the commercial marketplace.
› Verified 4 days ago
| NPI Number | 1649261025 |
| Organization Name | CITY VIEW NURSING & REHAB., LLC |
| Doing Business As | CITYVIEW NURSING AND REHABILITATION CENTER |
| Address | 6606 Carnegie Ave, Cleveland, OH 44103 |
| Phone Number | 216-361-1414 |
News Archive
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.
BioMimetic Therapeutics, Inc. announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).
Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.
The Life Sciences Discovery Fund (LSDF) today announced $1.1 million in five Proof of Concept grants to Washington for-profit and non-profit organizations to foster the translation of health-related products from the laboratory into the commercial marketplace.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.
BioMimetic Therapeutics, Inc. announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).
Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.
The Life Sciences Discovery Fund (LSDF) today announced $1.1 million in five Proof of Concept grants to Washington for-profit and non-profit organizations to foster the translation of health-related products from the laboratory into the commercial marketplace.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $6633 |
| Number of Payment Denials | 2 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.91 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.13 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.46 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.13 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.46 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 20.85 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 80.68 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.76 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 29.61 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.41 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 12.89 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.59 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.94 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 88.41 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 60.39 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 29.67 | 82.93 |
News Archive
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.
BioMimetic Therapeutics, Inc. announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).
Aficionados use words like "oaky" to describe some wines, or "hoppy" when talking about certain beers. But for rum—a product with over 1,000 different varieties—putting the words together to describe what imbibers are smelling and tasting is a bit more difficult.
The Life Sciences Discovery Fund (LSDF) today announced $1.1 million in five Proof of Concept grants to Washington for-profit and non-profit organizations to foster the translation of health-related products from the laboratory into the commercial marketplace.
› Verified 4 days ago
Franklin Plaza Extended Care Location: 3600 Franklin Boulevard, Cleveland, Ohio 44113 Phone: (216) 651-1600 | |
Rocky River Gardens Rehab And Nursing Ctr Location: 4102 Rocky River Dr, Cleveland, Ohio 44135 Phone: (216) 251-3300 | |
Euclid Beach Healthcare Location: 16101 Euclid Beach Blvd, Cleveland, Ohio 44110 Phone: (216) 486-2300 |